Stay updated on ECHO-204 Clinical Trial: Epacadostat + Nivolumab
Sign up to get notified when there's something new on the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page.

Latest updates to the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page
- Check4 days agoChange DetectedThe ClinicalTrials.gov page’s displayed site revision changes from v3.8.0 to v3.8.1.SummaryDifference0.0%

- Check11 days agoChange DetectedThe clinical trial record for the epacadostat–nivolumab ECHO-204 study is displayed, including study details, participant criteria, locations, and outcome measures. The record also includes study documents and the trial’s completed status.SummaryDifference86%

- Check18 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page itself still displays a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedA general NIH announcement about terminology changes appears above the unavailable study record, and the site revision identifier advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check46 days agoChange DetectedThe site footer revision label changed from v3.7.0 to v3.7.1 while the study page remains unavailable with a 403 Forbidden message.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content. This blocks access to the NCT02327078 record and its details for users.SummaryDifference21%

Stay in the know with updates to ECHO-204 Clinical Trial: Epacadostat + Nivolumab
Enter your email address, and we'll notify you when there's something new on the ECHO-204 Clinical Trial: Epacadostat + Nivolumab page.